findmyKOL
Clinical trialNCT05438576CompletedInterventional

Screening for Pregnancy Related Heart Failure in Nigeria

SponsorMayo ClinicEnrollment1,232CardiomyopathyPregnancy Related
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Nigeria
  • Rasheed Shekoni Specialist Hospital

    Dutse, Jigawa State, Nigeria

  • University of Ilorin Teaching Hospital

    Ilorin, Kwara State, Nigeria

  • Olabisi Onabanjo University Teaching Hospital

    Sagamu, Ogun State, Nigeria

  • University College Hospital

    Ibadan, Oyo State, Nigeria

  • Aminu Kano Teaching Hospital

    Kano, Nigeria

  • Lagos University Teaching Hospital

    Lagos, Nigeria

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Aug 2022
Primary completion
15 May 2024
Completion
15 May 2024
Last update posted
16 May 2025
Registered enrollment
1,232
Registry id
NCT05438576

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.